Funds will support the development of an innovative solution to improve care coordination.
“This Fast Track award is a strong validation of our work to bolster care for oncology patients, providers and caregivers,” said Howard Isenstein, founder of Care Progress. “These funds enable us to accelerate development of our technology within a large and growing market.”
The Fast Track award provides Care Progress with both Phase I and Phase II. Typically, companies need to apply for Phase II only after Phase I has been completed. The combined award will support a detailed development program including product design and validation, along with testing that will be performed in collaboration with world-class oncologists at Georgetown University Lombardi Comprehensive Cancer Center, which has been collaborating with Care Progress since 2014.
The new technology the company is developing under this award will dovetail with CarePrompter, Care Progress’s award-winning nurse triage/patient engagement software. Care Progress was one of five finalists out of 160 global entries in the Astellas Oncology C3 Prize competition.
About Care Progress
Care Progress, LLC develops innovative technology to improve patient outcomes, practice profitability and workflow. Further information is available at www.careprogress.com. The content is solely the responsibility of Care Progress and does not necessarily represent the official views of its partners or the National Cancer Institute.
Copyright © 2018.
CarePrompter is a trademark of Care Progress.
RELATED LINKS
http://www.careprogress.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20180315006059/en/
Source: Care Progress, LLC
View this news release online at:
http://www.businesswire.com/news/home/20180315006059/en
